Upakaar is live now for Order.

HomeShopMedicinesLINTOR M 850

LINTOR M 850

Lintor M 850 is a combination antidiabetic medication that contains Metformin Hydrochloride 850 mg and Glimiperide, typically used in the management of type 2 diabetes mellitus. It offers a dual mechanism of action — Metformin improves insulin sensitivity and reduces hepatic glucose production, while Glimiperide, a sulfonylurea, stimulates insulin release from the pancreas.

90.00

Ask about product

Description

Lintor M 850 is a combination antidiabetic medication that contains Metformin Hydrochloride 850 mg and Glimiperide, typically used in the management of type 2 diabetes mellitus. It offers a dual mechanism of action — Metformin improves insulin sensitivity and reduces hepatic glucose production, while Glimiperide, a sulfonylurea, stimulates insulin release from the pancreas.

This combination is ideal for patients who are not achieving adequate glycemic control with Metformin alone. Lintor M 850 helps manage blood sugar levels effectively and may reduce the risk of complications related to long-term uncontrolled diabetes.

Key Features:

  • Combines Metformin 850 mg with Glimiperide
  • Dual action: improves insulin sensitivity and boosts insulin secretion
  • Effective for patients with moderate to severe type 2 diabetes
  • Supports better glycemic control when monotherapy is insufficient
  • Convenient once-daily dosing (as advised by a physician)

Usage Instructions:

Take with meals to minimize gastrointestinal side effects. Follow the exact dosage and timing as prescribed by your doctor. Do not skip meals while taking this medication.

Storage:

Store in a cool, dry place away from moisture and direct heat. Keep out of reach of children.

Disclaimer:

To be taken under medical supervision. Inform your doctor about any other medications or health conditions. Regular blood sugar monitoring is advised during treatment.

Reviews

There are no reviews yet.

Be the first to review “LINTOR M 850”

Your email address will not be published. Required fields are marked *